Amna Al Futaisi

Amna Al Futaisi

Associate Professor of Pediatric Neurology in the Department of Child Health, College of Medicine and Health Sciences at Sultan Qaboos University
Al Khoud, Oman

Dr. Amna Al Futaisi did her training for pediatric residency program from the Montreal Children’s Hospital, McGill University, Canada from the year of 1998 till 2003, she also did her Pediatric electrophysiology/ epilepsy fellowship from the Hospital for Sick Children, University of Toronto, Canada. She has a Bachelor of Science from Sultan Qaboos University in 1990, she has a certification by RCPSC (pediatric neurology) in 2003, she also got her American Boards of Pediatrics in 2004 as well as a certification by RC or neurophysiology from Canada in the same year. She did was a fellow of Royal College of Pediatrics and Child Health in UK in the year of 2009.

Dr. Amna is a chairperson of hospital promotion committee & training committee. She is the associate program director in the pediatric program and a chairperson of curriculum subcommittee and examination subcommittee. She a member of the pediatric council in Arab Board of medical specialization and also a member of exam subcommittee, Arab Board. She is the vice president of Oman league Against Epilepsy.

Dr. Amna has done more than 50 publications and has interest in clinical research in the field of pediatric neurology, neurogenetics and epilepsy.

 

 

Short Description of the Lecture

1. Update: Autism & Epilepsy

Autism and epilepsy coexist. It is estimated that around 20-25% of population with autism develop a seizure in their life. Moreover, epileptiform abnormalities without concomitant clinical seizures are not uncommon in this population, they remain controversial in terms of their role in autism development and how to treat them. Most important risk factors to develop seizures in this population are intellectual disability, the coexistence of other neurological disorders, and certain medical conditions. Although, our understanding of the association between epilepsy and autism is still scarce, this association shouldn’t be overlooked and patients should undergo comprehensive investigations and assessment. Treatment approach of epilepsy in autism patients remains to be with conventional medical therapy. There is no consensus on a specific protocol to be followed in such patients. The treatment should be individualized, considering type of epilepsy, side effects, dose scheduling, associated comorbidities and patient’s preferences. More often, pharmacological treatment may need to be combined with behavioral therapy. Early recognition and comprehensive treatment of epilepsy and autism is of paramount.